Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Nitesh sinha September 25, 2023

https://ift.tt/yNkC2Ia

from Sanofi - Aventis Groupe https://ift.tt/IVwDCNz
via IFTTT

Post a Comment

0 Comments